跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gabasyn - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gabasyn
Approved
STANDARD
Gabasyn
Sydenham Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
175f9ca3f3576c54
Company
Sydenham Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
175f9ca3f3576c54
Drug Approval Philippines Name
Gabasyn
Product Name
Gabasyn
Registration Number
DRP-11956
Brand Name
Gabasyn
Generic Name
Pregabalin
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Sydenham Laboratories, Inc.
Issuance Date
24 May 2022
Expiry Date
24 May 2027
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
175f9ca3f3576c54
Type
Standard
Back to Philippines FDA Approvals